Title : Metformin attenuates early brain injury after subarachnoid hemorrhage in rats via AMPK-dependent mitophagy.

Pub. Date : 2022 Jul

PMID : 35341746






7 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Metformin attenuates early brain injury after subarachnoid hemorrhage in rats via AMPK-dependent mitophagy. Metformin protein kinase AMP-activated catalytic subunit alpha 2 Rattus norvegicus
2 Metformin is the most widely used drug to treat type 2 diabetes and its mitochondrial activity is through activation of adenosine monophosphate-activated protein kinase (AMPK). Metformin protein kinase AMP-activated catalytic subunit alpha 2 Rattus norvegicus
3 Metformin is the most widely used drug to treat type 2 diabetes and its mitochondrial activity is through activation of adenosine monophosphate-activated protein kinase (AMPK). Metformin protein kinase AMP-activated catalytic subunit alpha 2 Rattus norvegicus
4 The aim of this study was to investigate whether metformin could reduce early brain injury (EBI) after subarachnoid hemorrhage (SAH) by activating mitophagy and improving mitochondrial morphology through AMPK. Metformin protein kinase AMP-activated catalytic subunit alpha 2 Rattus norvegicus
5 Metformin treatment after SAH promoted mitophagy in an AMPK-dependent manner. Metformin protein kinase AMP-activated catalytic subunit alpha 2 Rattus norvegicus
6 In addition to the effects on mitophagy, we also found that metformin alleviated oxidative stress and apoptosis after SAH in an AMPK-dependent manner. Metformin protein kinase AMP-activated catalytic subunit alpha 2 Rattus norvegicus
7 Metformin attenuated EBI after SAH in rats through AMPK-dependent signaling. Metformin protein kinase AMP-activated catalytic subunit alpha 2 Rattus norvegicus